K Number
K030544
Device Name
RFX FLUROSCOPIC DIGITAL IMAGING SYSTEM
Manufacturer
Date Cleared
2003-05-21

(90 days)

Product Code
Regulation Number
892.1650
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The RFX Fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed.
Device Description
The RFX fluoroscopic digital imaging system allows the use of digital imaging to be applied to conventional X-ray system used in general fluoroscopy, interventional fluoroscopy, angiography and cardiac imaging areas. The system works by installing a CCD camera on the output port of the imaging intensifier and digitizing the video output of the image intensifier. The digital image can be displayed on the monitor; it can be stored to the hard drive, or sent to an external device such as a laser imager or Dicom Network Service Provider. The image can also be processed, including brightness and contrast, edge enhancement, zoom, and subtraction.
More Information

No
The description focuses on standard digital image processing techniques (brightness, contrast, edge enhancement, zoom, subtraction) and does not mention any AI or ML algorithms.

No

The RFX Fluoroscopic digital imaging system is described as an imaging system designed to replace conventional film techniques for diagnostic imaging procedures. It is used to view and enhance images, not directly treat patients.

Yes

Explanation: The device is used to acquire images for "diagnostic details" and for procedures like "general fluoroscopy, interventional fluoroscopy, angiography or cardiac imaging procedures," all of which are diagnostic in nature.

No

The device description explicitly lists hardware components such as a fluoroscopic CCD Camera, monitors, and an image processor, indicating it is not a software-only device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The RFX Fluoroscopic digital imaging system is used for in vivo imaging. It captures and processes images generated by X-rays passing through a patient's body during fluoroscopic procedures. It does not analyze samples taken from the body.
  • Intended Use: The intended use clearly describes its application in general fluoroscopy, interventional fluoroscopy, angiography, and cardiac imaging procedures, all of which involve imaging the inside of a living patient.

Therefore, the RFX Fluoroscopic digital imaging system falls under the category of medical imaging devices used for diagnostic purposes within the body, not for testing samples outside the body.

N/A

Intended Use / Indications for Use

The RFX fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed.

The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and enhanced enabling the operator to bring out diagnostic details difficult or impossible to see using conventional imaging techniques.

The RFX system enables the operator to print hardcopy images with laser printers, or send images over a network. The major system components are: fluoroscopic CCD camera, monitors, and image processor.

Product codes

OWB, JAA

Device Description

The RFX fluoroscopic digital imaging system allows the use of digital imaging to be applied to conventional X-ray system used in general fluoroscopy, interventional fluoroscopy, angiography and cardiac imaging areas. The system works by installing a CCD camera on the output port of the imaging intensifier and digitizing the video output of the image intensifier. The digital image can be displayed on the monitor; it can be stored to the hard drive, or sent to an external device such as a laser imager or Dicom Network Service Provider. The image can also be processed, including brightness and contrast, edge enhancement, zoom, and subtraction.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

X-ray

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K963037, K991578, K003434

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1650 Image-intensified fluoroscopic x-ray system.

(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

MAY 21 2003

K030544

510(K) Summary of Safety and Effectiveness

Date Prepared: February 12, 2003

Name of Contact Person: Omid Kia Address: Sigma Vision Inc. 6001 Montrose Rd. Suite 606 Rockville, Md. 20852 . Phone: 301.770.0052 Fax: 240.209.0798

Device trade name: RFX Fluoroscopic Digital Imaging System Common name: Digital Radiography System Classification Name: Image intensified fluoroscopic X-ray system

Device Description:

The RFX fluoroscopic digital imaging system allows the use of digital imaging to be applied to conventional X-ray system used in general fluoroscopy, interventional fluoroscopy, angiography and cardiac imaging areas. The system works by installing a CCD camera on the output port of the imaging intensifier and digitizing the video output of the image intensifier. The digital image can be displayed on the monitor; it can be stored to the hard drive, or sent to an external device such as a laser imager or Dicom Network Service Provider. The image can also be processed, including brightness and contrast, edge enhancement, zoom, and subtraction.

Intended Use:

The RFX fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed.

The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and enhanced enabling the operator to bring out diagnostic details difficult or impossible to see using conventional imaging techniques.

The RFX system enables the operator to print hardcopy images with laser printers, or send images over a network. The major system components are: fluoroscopic CCD camera, monitors, and image processor.

1

Conclusion drawn from comparison:

The RFX fluoroscopy digital imaging system can be considered to be substantially equivalent to:

INFIMED Inc. GOLDONE Fluoroscopic System (510K) ~ K963037 CMT Medical Technologies. SPOT / RAD System (510K), K991578 and K003434 and, virtually all of the features offered by the predicate devices are offered by the RFX product.

510(k) Number:

Unknown at this time

Device Name:

RFX Fluoroscopic Digital Imaging System.

Indications for Use:

The RFX Fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed.

The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and enhanced enabling the operator to bring out diagnostic details that might be difficult or impossible to see using conventional imaging techniques. Images can be stored locally for medium term storage.

The RFX system enables the operator to print hardcopy images with a laser printer or send images over a network for longer term storage. The major system components include: a fluoroscopic CCD Camera, monitors, and an image processor

PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, formed by three parallel lines that curve and taper to represent the feathers.

Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993

Omid Kia, Ph.D. Manager, Medical Imaging Products Sigma Vision, Inc. 6001 Montrose Rd., Suite 606 ROCKVILLE MD 20852

MAY - 7 2012

Re: K030544

Trade/Device Name: RFX Fluoroscopic Digital Imaging System Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: OWB and JAA Dated: February 12, 2003 Received: February 20, 2003

Dear Dr. Kia:

This letter corrects our substantially equivalent letter of May 21, 2003.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of

3

medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely Yours,

Janine M. Morris

Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

4

S10(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

Device Name: REX Frusses seatis Dicerns fraging

Indications For Use:

Indications for Use:

The RFX Fluoroscopic digital imaging system is a high resolution, digital imaging system designed for digital videography. It is intended to replace conventional film techniques in multipurpose or dedicated applications where general fluoroscopy, interventional fluoroscopy or angiography or cardiac imaging procedures are performed.

The RFX system allows the operator to view and enhance 1000 line fluoroscopy. High resolution digital spot images (1000 x 1000) may be acquired at single or rapid acquisition rates. Images may be viewed and cnhanced enabling the operator to bring out diagnostic details that might be difficult or impossible to see using conventional imaging techniques. Images can be stored locally for medium term storage.

The RFX system enables the operator to print hardcopy images with a laser printer or send images over a network for longer term storage. The major system components include: a fluoroscopic CCD Camera, monitors, and an image processor

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Nancy C. Brogdon

C

(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K030544

Prescription Use
(Per 21 CFR 801.109)

ത്ര

OR

Over-The-Counter Use

(Optional Format 1-2-96)